AIm: Monitoring of intracranial pressure (ICP), local cerebral blood flow (CBF) and oxygen is part of modern intensive critical care medicine. Preclinical evaluation of newly developed catheters that should monitor several parameters simultaneously is reported poorly in the literature. The goal of our study was (1) to evaluate a new multi-parametric sensor in brain tissue and (2) to establish a testing protocol using pathophysiological challenges that target measured parameters of the sensor and autoregulatory boundaries and could be used as preclinical standard protocol in future studies. mATERIAl and mEThods: We describe data from 12 new multi-parametric brain sensors (MPBS) that were implanted into 3 porcine brains and combined measurement of brain tissue oxygenation (ptiO 2 ), ICP, CBF and brain temperature for the first time. Pigs were treated with a period of hyperoxygenation, hypercapnia, hypoxia, dobutamine, and norepinephrine. REsulTs: None of the 12 MPBS failed. Our testing protocol induced standardized pathophysiological changes that were picked up by the new MPBS as significant alterations in brain ptiO 2 , ICP and CBF. The magnitude of changes was >20% in most tested MPBS. CoNClusIoN: An experimental protocol with pre-defined end-points for O 2 , CO 2 , blood pressure and cardiac output should be standardized and reported if new sensors for multi-parametric brain monitoring are evaluated. The use of several sensors per brain of only a few animals is sufficient to determine functionality of new sensors in vivo as basis for a larger study with reference sensors and brain injury. KEywoRds: ICP, Multi-parametric neuromonitoring, Hypercapnia, Hyperoxygenation, Hypoxia, Pig ÖZ AmAÇ: İntrakraniyal basınç (İKB), yerel serebral kan akışı (SKA) ve oksijenin izlenmesi modern yoğun bakım tıbbının bir parçasıdır. Literatürde aynı anda birkaç parametreyi izleyecek yeni geliştirilmiş kateterlerin preklinik değerlendirmesi hakkında çok az bilgi vardır. Çalışmamızın amacı, (1) beyin dokusunda yeni bir multi-parametrik sensörü değerlendirmek ve (2) sensör ve otoregülasyon sınırlarını hedefleyen patofizyolojik değişiklikler kullanan ve gelecekteki çalışmalarda preklinik standart bir protokol olarak kullanılabilecek bir test protokolü belirlemekti. yÖNTEm ve GEREÇlER: Üç domuz beynine implante edilen 12 yeni multi-parametrik beyin sensörü (MPBS) ve ilk kez beyin dokusu oksijenizasyonu (ptiO 2 ), İKB, SKA ve beyin sıcaklığının kombine ölçümüyle ilgili veriler sunuyoruz. Domuzlar hiperoksijenasyon, hiperkapni, hipoksi, dobutamin ve norepinefrin dönemlerinden geçti. BulGulAR: 12 MPBS'den hiçbiri başarısız olmadı. Test protokolümüz yeni MPBS tarafından beyin ptiO2, ICP ve SAK değerlerinde önemli değişiklikler olarak saptanan standardize patofizyolojik değişikliklere neden oldu. Değişikliklerin büyüklüğü çoğu test edilen MPBS ile %20 civarındaydı. soNuÇ: O 2 , CO 2 , kan basıncı ve kardiyak çıktı için önceden tanımlanmış son noktaları olan deneysel bir protokol standardize edilmeli ve multi parametrik beyin izleme için yeni sensörler değerlendirilirse bunlarla sonuçlar bildirilmelidir. Sadece birkaç hayvanda her beyinde birkaç sensör kullanılması yeni sensörlerin in vivo olarak referans sensörler ve beyin hasarıyla daha büyük bir çalışmanın temeli olarak kullanılmasına karar vermek açısından yeterlidir.
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InTROdUcTIOn
Increased intracranial pressure (ICP), reduced cerebral perfusion pressure (CPP) and local changes of cerebral blood flow (CBF), oxygen and substrate delivery as well as release of neurotoxic mediators mark the pathophysiology of severe traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH) (12) . Advanced neuromonitoring in the intensive care unit includes measurements of continuous ICP, brain tissue oxygenation (ptiO 2 ) and extracellular energy metabolites by microdialysis and intermittent measurements of CBF by CT-scan. Gathered information can be used for maintaining adequate ICP, CPP and brain oxygenation. Experimental and clinical studies have shown the benefits of such multiparametric neuromonitoring for patients following severe TBI or SAH (3) . Until recently, implanted catheters measured only a single modality, e.g. oxygen tension by Licox® catheters, and two or more catheters had to be implanted into brain tissue in order to collect several parameters simultaneously. This makes handling of multi-parametric neuromonitoring work intensive and a combination of sensors in a single catheter is desirable. A first step was the integration of the separately implanted temperature probe from Licox into a new Licox-PMO catheter (Integra LifeSciences, USA) combining tissue oxygen measurement by a Clark-type electrode with temperature measurement by a thermistor element (35) . A further step was the integration of a pressure sensor for ICP, luminophores (silicone-soluble fluorescence dye complex) for oxygen and a thermocouple for temperature measurement in a single catheter by Raumedic (Neurovent-PTO). First experimental and clinical comparison of the standard method (Licox CC1.SB; Clark-type electrode) with Neurovent-PTO (luminophores) showed a good correlation for oxygen (6, 27) . Thus, combining various sensors in one catheter with an acceptable size (diameter eg. 5F) and performance is feasible. However, a literature review shows that there seems to be no consensus about a standardized protocol how to test new multi-parametric sensors.
In collaboration with Oxford Optronix Ltd. (Abingdon, UK) and Millar Instruments (Houston, USA) we now extended the range of parameters by merging a Laser-Doppler and sensors for ICP, ptiO 2 and temperature into one catheter. A trial run with a first sensor design already called for modifications, although this first series of sensors reacted well in vitro. In order to test whether or not the newly designed multi-parameter catheter works in brain tissue we implanted a total of 12 catheters (4/ animal) into the porcine cortex and provoked reactions of each sensor unit by physiological, pathophysiological and pharmacological manipulations. The results should provide evidence (1) for the functionality of the MPBS in vivo and (2) for the importance of a standardize protocol to evaluate new multi-parametric sensors. Data of this small scale study should be the basis for a large in vivo experimental series using the new sensors in combination with standard reference sensors and an injury model.
MATeRIAl and MeTHOdS
Multi-parameter brain sensor (MPBS, Oxford Optronix Ltd., Abingdon, UK)
As depicted in Figure 1 the new catheter consists of four units measuring oxygen tension, temperature, pressure and blood flow via laser Doppler flowmetry simultaneously. The units are arranged along a steel shaft (length: 14.5 mm; diameter: max. 1.97 mm, tip 0.97 mm) and the implemented measuring technology is described below: ptiO 2 (and temperature) Measuring Principle
The ptiO 2 sensing part of the MPBS probe is based on fibreoptic light guides and provides a continuous measure of oxygen partial pressure for real-time monitoring of temporal oxygen changes in the cerebral tissue.
A fluorophore is permanently immobilised and enclosed within a silicone matrix under the metal caging. The lifetime of fluorescence is inversely proportional to the concentration of dissolved oxygen and is interpreted to provide an absolute value for ptiO 2 in mmHg or kPa.
Fluorescence lifetime is longest at low ptiO 2 , making the sensor most sensitive in the physiological range 0-60 mmHg. The measurement is based on fluorescence lifetime rather than fluorescent intensity.
Compensation for the effects of temperature is required since fluorescent lifetimes are affected by changes in temperature. This is done by a fully integrated thermocouple in the MPBS sensor, allowing continuous monitoring of temperature as well as automatic (background) temperature correction for the ptiO 2 values.
The probe is pre-calibrated by the manufacturer and requires no further intervention. As a standard procedure for evaluation of new probes we placed the catheters in distilled water bubbled with air as well as in a solution with no free oxygen (0.26g sodium tetraborat, 1.63g sodium sulfite, 1L dest. water).
Laser Doppler Flowmetry Principle
Laser Doppler flowmetry is an established technique for the real-time measurement of microvascular red blood cell (erythrocyte) perfusion in tissue (e.g. 7).
The MPBS probe has two integrated optical fibre light guides for measuring microvascular blood perfusion. Laser light goes through one fibre and is scattered within the tissue. Another optical fibre collects the backscattered light from the tissue and returns it to the monitor.
Most of the scattered light is from tissue that is not moving but a small percentage of the returned light is scattered by moving red blood cells. The light returned to the monitor undergoes signal processing whereby the emitted and returned signals are compared to extract the Doppler shift related to moving red blood cells. The obtained microvascular blood perfusion signal is the product of mean red blood cell velocity and mean red blood cell concentration in the volume of tissue under illumination from the probe. It is expressed in relative units called Blood Perfusion Units (BPU). These relative BPU are defined over a scale by the manufacturer using a carefully controlled motility standard comprising a suspension of latex spheres undergoing Brownian motion. Nevertheless, a 'biological zero' was established after cardiac arrest following 7.45% potassium chloride (KCl, B.Braun, Melsungen, Germany) injection.
ICP (Intracranial Pressure)
ICP is an established and accepted method for real-time pressure measurement of brain tissue and fluids alike. The MPBS probe uses Millar solid-state Micro-Electro-Mechanical Systems (MEMS) sensor technology for its pressure measurement technology. The MPBS catheter assembly houses micro-miniature piezo-resistive ½ bridge (2 active) sensors that are completed in a Wheatstone bridge. This bridge forms a pressure transducer that produces voltage being proportional to the pressure applied to the pressure sensor surface. The specific monitoring equipment filters, amplifies and displays the particular pressure waveforms in real-time.
This MEMS technology allows for a micro-miniature sensor to be used at a high frequency response capability. This microminiature sensor also allows room for the other optical fibers required for the other sensors already mentioned within the MPBS lumen. Since solid-state technology is used vs. fluid-filled the pressure is measured at the point source and not through a water filled tube. Also the pressure sensing capability is such that very small pressure changes can be detected. Finally due to the solid-state technology being used, high frequency artefacts of the pressure waveform can be analysed if required.
1-Animals and surgical procedures
All experiments were approved by the ethical committee for Animal Use and Care and performed according to national guidelines for animal experiments. Three (3) juvenile male pigs at the age of 3-4 months (German breed; 29-32 kg) were used. Initial medication consisted of i.m injection of ketamine (15 mg/kg), azaperone (3 mg/kg; Sanochemia Pharmazeutika, Neufeld, Austria) and atropine (1 mg, B.Braun AG, Melsungen, Germany). After cannulation of an ear vein 10 ml thiopental (25 mg/ml; Trapanal, Nycomed, Konstanz, Germany; #PZN-1037554) was injected. Thereafter, thiopental was infused continuously at a rate of 10-15 mg/kg bw/h. Piritramid (1 mg/ ml; Dipidolor, Janssen-Cilag Pharmaceuticals GmbH, Neuss, Germany,; #PZN-1312724) was used for analgesia at a rate of 0.2-0.3 mg /kg bw/h. All animals were intubated (SuperSafety-Clear, i.d/o.d. 6.0/5.5 mm, Teleflex, Rüsch, Germany) and mechanically ventilated (900B; Siemens-Elema AB, Erlangen, Germany). FiO 2 and etCO 2 were monitored throughout the experiment (Capnomag Ultima; Datex Engstrom Division, UK). Pigs were placed on a heating pad (Homeothermic Blanket Systems, Harvard Apparatus, Hugo Sachs Elektronik, MarchHugstetten, Germany) and body temperature was kept at 38.5±1.5 °C. No muscle relaxation was employed.
Surgical Preparation
The femoral artery and vein were cannulated for blood pressure monitoring, withdrawal of blood for blood gas analysis and volume therapy. The jugular vein was cannulated for hemodynamic and cardiac parameters such as the cardiac index (CI), systemic vascular resistance (SVR) and systemic vascular volume (SVV) by PiccoPlus (PULSION Medical Systems AG, München, Germany). Animals were fixed in a stereotaxic frame and a skin incision was made to expose the skull. The periosteum was carefully removed and the bone disinfected. Burr holes for probe insertion were drilled over the left and right cortex (two burr holes/hemisphere, MicroTron 60, Aesculap, Germany). The dura mater was perforated using a sterile needle (G20) to allow probe insertion to an initial depth of 15 mm. After placement each probe was fixed in place using bone wax (Johnson&Johnson Medical, Norderstedt, Germany).
2-Study protocol
The goal of the study protocol was to induce an increase, decrease or no change of measured values from baseline in uninjured tissue, i.e. to challenge the four different parameters of MPBS ( Figure 2 ). Therefore, brain ptiO 2 was manipulated by hyperoxygenation (arterial pO 2 > 400 mmHg) and hypoxia (arterial pO 2 < 40 mmHg). We achieved hyperoxia by increasing FiO 2 and hypoxia by ventilation with an air/N 2 mixture. Changes of ICP and CBF were induced by hypercapnia (paCO 2 > 70 mmHg) and also by hypoxia. Hypercapnia was induced by the method of apnoeic oxygenation. During a 15-min episode, ventilation was discontinued but lungs were flooded with oxygen by means of an inserted tube. Thus, (Figure 2 ). Before the first and after each challenge a recovery period was inserted which lasted for 15 min or until stable values were reached again.
Data Analysis
Data were recorded at 1Hz and plotted real-time using LabChart Software (ADInstruments). Data were transferred to Sigmaplot (Systat Ldt.) to display them as online recording and as mean 5-min average (±SD). A paired t-test was used to compare baseline values before each challenge with the 5, 10 and 15-min time point of the particular challenge.
ReSUlTS
A total of 12 MPBS in three pigs were tested yielding a total of 180 datasets (dataset = baseline + 15-min challenge). As described in Table I some datasets were rejected due to malfunctioning sensors, incomplete sampling or accidental MPBS manipulation. Figure 3A and 4A-C show online recordings of the same MPBS reacting to an episode of hyperoxygenation, hypercapnia, hypoxia and treatment with dobutamine and norepinephrine.
Brain Tissue Oxygen
Although ptiO 2 started at different baseline levels (range: 1.6-49.2 mmHg) all MPBS reacted to hyperoxygenation and hypoxia (Table I) . Only subtle effects were seen during dobutamine and norepinephrine infusion. Statistical comparison between baseline and the 5-, 10-and 15-min time-point within challenges indicated that a significant number of O 2 -sensing modules picked-up even small changes during dobutamine infusion ( Figure 3B ). Mean ptiO 2 at beginning of the protocol was 17.4±18.3 mmHg and declined only slightly to 14.4±11.0 mmHg just before the hypoxic episode. The highest brain tissue oxygen levels were reached in all cases at the end of increased FiO 2 with 31.4±31.6 mmHg (blood oxygen 528±49 mmHg). All sensors showed a decline of ptiO 2 to a minimum of 2.2±2.2 mmHg at the end of hypoxia (blood oxygen 25±4 mmHg). Flooding of lungs with oxygen during apnoeic oxygenation could not keep blood oxygen at a constant level. Therefore, ptiO 2 is not shown in Figure 3 and Table I in order not to provoke false interpretation of ptiO 2 changes due to increased paCO 2 .
Intracranial Pressure
Baseline ICP ranged from 5.1 to 16.9 mmHg for the 12 MPBS in the three pigs at the beginning of the experimental protocol (mean: 10.4±3.0 mmHg). After each challenge ICP returned to baseline level and there was no permanent change of mean ICP until the end of the protocol (12.2±11.2 mmHg; Figure 4A , B). ICP changes could be evoked by hypercapnia (paCO 2 = 104±2.6 mmHg) and hypoxia. ICP rose to a maximum of 25.9±9.7 mmHg and 20.3±10.3 mmHg at the end of the hypercapnic and hypoxic episode, respectively. Similar to the O 2 -sensing module a significant number of the pressure modules picked-up even small changes during treatment with dobutamine and norepinephrine ( Figure 4B ). blood remained oxygenated but no effective CO 2 exchange takes place anymore. Since thiopental already suppressed spontaneous breathing no additional medication for muscle relaxation was necessary. No specific manipulation was induced for temperature that should follow changes of CBF passively. No alteration of ptiO 2 , ICP, CBF and temperature was expected at intact autoregulation by manipulation of mean arterial blood pressure (MAP) by infusion of norepinephrine (0.2 / 0.4 / 0.6 µg/kg/h; Arterenol, Sanofi-Aventis, #PZN-7800040) and cardiac output by dobutamine (5, 10, 15 µg/ kg/h; Carinopharm GmbH, #PZN-4344877).
Hyperoxygenation and hypercapnia lasted for 15 min. Both pharmacological manipulations consisted of a continuous, stepwise increase of the infused concentration of norepinephrine or dobutamine. Each step also lasted for 15 min. The hypoxic period lasted for a maximum of 10 min in order to Figure 2 : Schematic drawing of the experimental protocol for the evaluation of multi-parameter sensors. The protocol starts with an equilibration time of 60-120 min followed by a 15-min baseline. Subsequently a series of physiological and pathophysiological manipulation (10-45 min) are performed in order to challenge sensors differently. Each challenge is followed by a normalization period of at least 15 min or until stable values are reached. Introduction of a brain injury by e.g. focal ischemia or controlled cortical impact could be used to damage autoregulatory mechanisms and would allow to detect effects of dobutamine and norepinephrine. Our first tests on three pigs were performed without previous injury. (±50 mmHg), hypoxemia and finally MCA occlusion in cats. They have been able to evoke the intended changes and to evaluate the new sensor partially by means of an elaborate testing protocol. Despite excellent in vitro performance (1,13), production has been discontinued because the Neurovent probe was instable in long-term measurements in vivo.
Orakcioglu and coworkers compared Licox probes with the new oxygen-temperature sensor Neurovent-TO (Raumedic, Germany) in a porcine model (27) . The purpose of their protocol was to evoke various ptiO 2 A less complex oxygen protocol was used by Morgalla et al. 
Cerebral Blood Flow
Individual differences of BPU were higher than variability of oxygen or pressure monitoring throughout the experiment.
Baseline BPU values ranged from 106 to 2248 BPU. Although mean CBF varied during hyperoxygenation, blood flow remained stable during dobutamine and norepinephrine treatment ( Figure 4D ). As shown in Figure 4C , treatment with dobutamine did cause a slight increase of CBF. Through the entire protocol CBF changed from 756±617 BPU (baseline before hyperoxygenation) to 595±389 BPU (before hypoxia). Both, the hypercapnic and hypoxic provocation produced changes of CBF that could be detected by the MPBS. On average, elevation was more pronounced during hypercapnia (20% increase: 582±329 to 711±358 BPU) than during the hypoxic episode (595±389 to 606±378 BPU). Statistical analysis by paired t-tests of baseline versus the different time-points during each challenge showed that a significant number of Laser-Doppler units picked-up mainly early induced changes ( Figure 4D ).
The Laser-Dopplers were tested for its 'biological zero' by means of cardiac arrest (KCL injection) in one pig. CBF values dropped to almost zero i.e. 3.2% of baseline value, within 120 s of KCL-injection ( Figure 5 ).
Experimental Protocol
Provocations for MPBS parameters were controlled by blood gas analysis and measurement of hemodynamic parameters (e.g. blood pressure, cardiac output, peripheral resistance). Hyperoxia, hypoxia and hypercapnia caused the intended significant change of paO 2 and paCO 2 , respectively as shown in tables below Figure 3A ,B; 4A-D. Treatment with dobutamine increased cardiac output and reduced peripheral resistance. The expected blood pressure increase by norepinephrine could not be found whereas the highest concentration led to an elevation of heart rate (from 117±5 to 134±18 bpm) and systolic pressure (from 125±0.7 to 141±7 mmHg).
dIScUSSIOn
An ideal protocol for evaluation of new multi-parametric sensors should include phases during which a particular parameter or a set of parameters is manipulated in a controlled direction. For instance, increased blood paCO 2 leads to vasodilation and consequently to elevated blood flow in unharmed tissue. Thus, a hypercapnic episode could be used to evaluate a CBF sensor. A sensor evaluation could be extended further by combining such manipulations with animal models of ischemic or traumatic brain injury with wellknown pathophysiological changes.
Following these principles, Zauner and coworkers tested a multi-parametric probe (Neurotrend, Codman&Shurtleff, Raynham, USA) that measured oxygen, carbon dioxide, pH and temperature in a single catheter (1, 42) . Their experimental protocol consisted of hypo-and hypercapnia by hyperventilation (paCO 2 = 22±3 mmHg) and hypoventilation (paCO 2 = 47±4 mmHg), ICP increase via intraventricular saline infusion state of hypercapnia as this should cause an increase in CBF by about 50 % (37). Starting from this level there is a good correlation with ICP and MAP in piglet (28). Thus, significant changes of CBF and ICP in brain tissue can be expected. In order to achieve such high paCO 2 values we applied the apnoeic oxygenation that resulted in hypercapnia method. Alternatively, blood carbon dioxide could be increased by reducing the respiratory rate (38) . This has the disadvantage that high paCO 2 levels are difficult to reach without a risk of low oxygenation. Furthermore, a paCO 2 > 70 mmHg is hard to reach using this method. For evaluation of ICP and CBF of a new multi-parametric probe a more pronounced increase from baseline would be desirable. Other methods to reach higher paCO 2 could be the loading of inspired air/O 2 mixture with a predefined concentration of CO 2 (9, 14, 22) or to disconnect mechanical ventilation with simultaneous flooding of lungs with oxygen. The latter method can reliably raise paCO 2 over 100 mmHg. Since monitoring of inspired air is discontinued, pulsoxymetry on the pig's tail or ear allows an estimation of a sufficient blood oxygen level. Fig 4A/ B indicates clearly that ICP can be elevated (from 10 mmHg to 23 mmHg) using apnoeic oxygenation. There is a positive relationship between paCO 2 and ICP due to the attempt to remove CO 2 from brain by increasing CBF (11, 30, 41) . Consequently, a larger blood volume in the brain (CBV) causes ICP to increase under physiological conditions (18) . Therefore, apnoeic oxygenation is also a good method to evaluate CBF measurements by MPBS or other probes. Almost 80% of MPBS showed a relative increase in CBF of more than 10 % due to hypercapnia (Table  I , Figure 4C ,D). Unexpectedly, two probes picked-up a CBF decrease (>10%) during hypercapnia ( Table I ). The degree of CBF elevation varied between the sensors. The considerable SD of the CBF values (BPU), which is conditioned by unequal reactions of the respective probes, might be due to both the particular location and depth of the probes within the brain tissue. The measurement of CBF by LDF can be affected by microscopic structures near the probe tip as only a small brain volume is monitored (4). For example, positional variability in blood vessel diameters may influence baseline CBF. Proximity to arterioles might also bias the measured values (14) . Thus, local CBF recorded with LDF may not necessarily show good correlation with the real regional CBF, though relative changes in perfusion can be detected satisfactorily (7). Hemorrhage and trauma caused by implantation of the MPBS may also have had a distorting effect. This is compounded by our relatively short equilibration time of only 30 min. However, these factor may only partially explain why MPBS did not pick up the expected 50% CBF change at the reached hypercapnic level.
A hypoxic episode was included to test sensors at low ptiO 2 and to cause brain swelling as well as an increased CBF (32) . We used a mixture of air/N2 to induce a drop in paO 2 but could simultaneously keep paCO 2 constant. Thus, an impact of paCO 2 on ICP and CBF was excluded. Figure 4C indicates that CBF increased immediately after the start of hypoxia in order to provide more oxygen to the brain tissue. The These examples show that there seems to be no consensus how new single-or multi-parametric brain sensors should be evaluated in a standardized manner and that challenging factors are poorly reported. A protocol should include not only maneuvers that manipulate measured values in brain tissue, but also upper and lower limits for targeted parameters (e.g. blood pressure, heart rate, arterial pO 2 , pCO 2 , ICP). These borders and the actual values should be defined and reported in publications -which is seldomly done. ptiO 2 is often the sole focus in publications despite the use of multi-parametric probes. The measurement of all MPBS parameters -ptiO 2 (17, 25, 34, 36, 39) , ICP (8, 16, 21, 26, 28, 29) , CBF (4,5) and brain temperature (33) -is considered useful, and can predict and maybe influence outcome. Our goal was to include all those parameters in one test protocol. Therefore, we manipulated brain oxygen by episodes of hyperoxygenation and hypoxia. We demanded an arterial pO 2 of >400 mmHg and <40 mmHg, respectively, in order to standardize our protocol. These paO 2 limits have been reached without difficulty in all three pigs by increasing FiO 2 . This manipulation of ptiO 2 via hyperoxic ventilation has similarly been employed in the aforesaid probe evaluations and other studies (19, 20, 31, 40) . As shown in Figure 3A ,B all MPBS reacted as expected and manipulating FiO 2 for sensor evaluation is a valid method.
Ursino et al. (37) showed that the radius of vessels increases until a blood paCO 2 of around 70 mmHg in large pial vessels and continues to increase above 70 mmHg in small pial vessels. Therefore we used a paCO 2 of >70 mmHg to standardize the duration of this effect is limited, counteracted by an ICP increase and a drop of CBF follows. The dynamic of CBF, ICP and ptiO 2 changes differed between the animals. Whereas a more than 20% change was found for all ptiO 2 and ICP sensors, 56% of CBF increased and 44% decreased by more than 10% . Consequently, a hypoxic episode can only be used for parameter comparison with a high rate of data recording and within an individual animal or by using reference probes. Averaging as shown in Figure 3B , 4B and 4D might only be useful if stable inclines or declines of values are achieved by a particular maneuver (e.g. end of hypoxic period). However, the drop of CBF to almost 0 after cardiac arrest ( Figure 5 ) shows the validity of the Laser-Doppler unit of the MPBS sensor.
Our protocol also included an attempt to manipulate cardiac output by dobutamine and blood pressure by norepinephrine. According to the Bayliss effect, CBF is tightly controlled between a mean arterial blood pressure of 50 to 150 mmHg as vascular smooth muscles contract in response to stretch (2, 11, 24) . Increasing cardiac output with a simultaneous decrease of systemic vessel resistance (dobutamine) or an elevated blood pressure (norepinephrine) should only have little effect on ptiO 2 , ICP and CBF as long as blood vessel function is intact and/or autoregulatory limits are not reached. In our tests, dobutamine increased CI by 1 l/ min/m 2 and decreased SVR by 221 dyn × s/cm 5 l (15 µg/kg/h after 45 min). The application of norepinephrine resulted in a minimal increase in CI and a rise in SVR by 108 dyn × s/cm 5 but failed to elevate mean arterial blood pressure (even at the highest dose of 0.6 µg/kg/h after 45 min). As expected, neither dobutamine nor norepinephrine administration was able to influence ptiO 2 , ICP or CBF considerably and no longterm peaks were observed. Statistical comparison of baseline values with the 3 time-points within challenges indicated, however, that small changes were induced by dobutamine and norepinephrine and could be picked-up the by MPBS ( Figure 3B , 4B/D). In order to test the ability of a probe to detect an impaired vascular autoregulation it might be feasible to conduct this protocol also in brain injured animals. This might also accentuate CBF changes induced during hypoxia.
The protocol manipulates ptiO 2, CBF and ICP reliably and is feasible for evaluation of multi-parametric brain probes like the new MPBS. Most modules of the 12 MPBS reacted as expected during and between the challenges and showed its basic functionality even when combined in a single catheter. Inclusion of challenge repetition might even improve the quality of gathered information. Although most MPBS reacted to challenges as expected the high standard deviation of the 12 sensors indicate that the position of a multi-parametric sensors in the porcine brain influences not only the measured level but also the magnitude of changes.
We propose that this small-scale study protocol should be introduced in pre-clinical evaluation practice as a basis for larger comparative (use of reference probes) and more complex studies (traumatic brain injury, ischemia). This step-
